Failing to take all of these other problems into account constitutes a major oversight in any story about the drug crisis. What is more, overzealous focus on big pharma and prescription opioids ...

Trump has good reasons to take on Big Pharma. While the U.S. is the biggest and most lucrative market globally for prescription drugs and generic products, or those that have come off-patent ...

With the ascendancy of Trump, it is open season on profiteering and big pharma is no exception ... the middle of a cost-of-living and housing crisis; Trump is wreaking geopolitical havoc ...

I found the timing and tone of the article on reproducibility particularly interesting ... Currently, those investigations are almost a sham. Big named faculty get away with even the most ...

And while Americans would compromise their health, Big Pharma would continue raking in profits. The United States is ...

That's according to more than half a dozen pharma industry sources. In conversations with U.S. officials, the pharmaceutical industry has reportedly argued that tariffs on the EU would increase ...

As reported in Tuesday’s Irish Times, big pharma lobby groups have been trying to get Ireland to support their case that proposed EU changes to laws on drug patents would damage research ...

How would you feel if you knew your doctor was getting paid by big pharma? Would you still trust their medical advice? Every ...

Wes Streeting, the Health Secretary, is understood to have had meetings with pharma chiefs to discuss plans to support the life sciences sector Credit: Eddie Mulholland for The Telegraph It would ...